University of Wisconsin
Madison, Wisconsin, 53792, United States
Location status: Recruiting
NCT Number: NCT07430839
The purpose of this study is to determine 1) if young adults with metabolic syndrome display endothelial dysfunction of the internal carotid artery in a sex-specific fashion and 2) if this endothelial dysfunction can be acutely improved with a single bout of exercise. This will be achieved by testing internal carotid artery function before and after a 30-minute bout of moderate intensity exercise. 48 young adults with and without metabolic syndrome will be enrolled and will be on study for approximately 5.5 hours over 4 study visits.
Interested in participating?
Request Info18 year–40 year
All sexes
Observational
Madison, Wisconsin, 53792, United States
Location status: Recruiting
The goal of this project is to determine if young MetSyn patients exhibit carotid endothelial dysfunction (ED) in a sex-specific manner and if exercise can acutely restore internal carotid artery (ICA) function.
The investigators will test this by first quantifying ICA endothelial function using an inhaled gas stressor (CO2) to acutely increase ICA shear rate (SR) and measuring the vascular responsiveness to this increased SR. Carotid endothelial function has never been tested in this way in patients with MetSyn before. Then, a 30 min bout of cycling exercise will be performed followed by the same gas stressor test to determine if ICA endothelial function can be acutely improved in MetSyn.
The aims and hypotheses are to:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(MetSyn cohort):
Inclusion criteria
(Healthy cohort):
Exclusion criteria
Exclusion criteria
(healthy controls only):
30 minute bout of cycling
Three gases of different composition are used to ensure that the proper PETCO2 administration desired for this study occurs in tandem with keeping inspired O2 content constant. This is achieved by used a 5% O2, 95% CO2 tank, a 5% O2, 95% N2 tank, and a 100% O2 tank. In tandem, the use of these three tanks allows for precise control of PETCO2 without a change in inspired O2.
Time frame: baseline
Internal carotid artery cerebral shear-mediated dilation (cSMD) is measured by doppler ultrasound and reported in percentage increase in diameter. A resting baseline period for 5 minutes breathing room air followed by 30 seconds of breathing CO2-mixed air at +9 mmHg PETCO2 used to evoke an increase in blood flow to the ICA.
Time frame: baseline
Internal carotid artery cerebral shear-mediated dilation is measured by doppler ultrasound and reported in percentage increase in diameter. A resting baseline period for 5 minutes breathing room air followed by 30 seconds of breathing CO2-mixed air at +9 mmHg PETCO2 used to evoke an increase in blood flow to the ICA.
Time frame: measured during exercise and 10 and 60 minutes post-exercise
Internal carotid artery cerebral shear-mediated dilation is measured by doppler ultrasound and reported in percentage increase in diameter. 30 minutes of exercise on a cycle ergometer will be performed at 80% of the ventilatory threshold determined during the graded exercise test.
Time frame: measured during exercise and 10 and 60 minutes post-exercise
Duration of post-exercise improvements will be investigated by testing ICA cSMD 10 min and 60 min post-exercise. 30 minutes of exercise on a cycle ergometer will be performed at 80% of the ventilatory threshold determined during the graded exercise test. For the duration of the exercise, indirect calorimetry will be used to assess VO2 to confirm the target workload of 80% of the ventilatory threshold. During this 30 minutes of exercise, ICA diameter and velocity will be measured using ultrasonography every 5 minutes for a 2-minute period.
Contact information is provided by the study sponsor or research team.
Logan Heenan, BS
CONTACT
Shawn Bolin, MS
CONTACT
University of Wisconsin, Madison
Other
Identifying Sex-specific Carotid Endothelial Dysfunction in Young Adults With Metabolic Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05585190
Behavior, Body Weight
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06857929
Behavior, Body Weight
Madrid, Spain
View Trial DetailsNCT07296991
Behavior, Glucose Metabolism Disorders
Detroit, Michigan, United States
View Trial DetailsNCT06377254
Age-Related Sarcopenia, Age-related Cognitive Decline
Nottingham, Notts, United Kingdom
View Trial Details